FDA inspection
Novartis Pharmaceuticals A. G.: FDA inspection ending Mar 23, 2017
FDA inspection 1009385 · Voluntary Action Indicated (VAI) · Broomfield, CO
Key facts
| Inspection ID | 1009385 |
|---|---|
| Firm | Novartis Pharmaceuticals A. G. |
| FEI number | 3013367255 |
| Address | 11101 W 120th Ave Ste 120 |
| City | Broomfield |
| State | CO |
| ZIP | 80021 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Mar 23, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data